Patents by Inventor Gil Rivas
Gil Rivas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210186417Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of th4e analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: October 28, 2020Publication date: June 24, 2021Inventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Patent number: 10677688Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: GrantFiled: April 18, 2017Date of Patent: June 9, 2020Assignee: OptiScan Biomedical CorporationInventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Publication number: 20180067019Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: ApplicationFiled: April 18, 2017Publication date: March 8, 2018Inventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Publication number: 20170188943Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: August 15, 2016Publication date: July 6, 2017Inventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Patent number: 9632013Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: GrantFiled: September 14, 2012Date of Patent: April 25, 2017Assignee: Optiscan Biomedical CorporationInventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Publication number: 20160371451Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: ApplicationFiled: March 21, 2016Publication date: December 22, 2016Inventors: Peter Rule, Gil Rivas
-
Patent number: 9414782Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: GrantFiled: September 14, 2012Date of Patent: August 16, 2016Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Patent number: 9289169Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: GrantFiled: November 22, 2013Date of Patent: March 22, 2016Assignee: OptiScan Biomedical Corp.Inventors: Peter Rule, Gil Rivas
-
Publication number: 20140275868Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: ApplicationFiled: November 22, 2013Publication date: September 18, 2014Applicant: OptiScan Biomedical CorporationInventors: Peter Rule, Gil Rivas
-
Patent number: 8597190Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: GrantFiled: December 13, 2010Date of Patent: December 3, 2013Assignee: Optiscan Biomedical CorporationInventors: Peter Rule, Gil Rivas
-
Publication number: 20130165900Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: September 14, 2012Publication date: June 27, 2013Applicant: OPTISCAN BIOMEDICAL CORPORATIONInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Publication number: 20130160532Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: ApplicationFiled: September 14, 2012Publication date: June 27, 2013Applicant: OptiScan Biomedical CorporationInventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Patent number: 8470241Abstract: Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.Type: GrantFiled: May 19, 2008Date of Patent: June 25, 2013Assignee: Optiscan Biomedical CorporationInventors: Gil Rivas, Michael Butler, Jeffrey T. Chiou, Eugene Lim
-
Patent number: 8449524Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: GrantFiled: June 30, 2011Date of Patent: May 28, 2013Assignee: Optiscan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Publication number: 20120203089Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: ApplicationFiled: December 13, 2010Publication date: August 9, 2012Inventors: Peter Rule, Gil Rivas
-
Publication number: 20110264071Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: June 30, 2011Publication date: October 27, 2011Applicant: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Patent number: 7972296Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: GrantFiled: October 10, 2008Date of Patent: July 5, 2011Assignee: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman
-
Publication number: 20090160656Abstract: Some embodiments disclosed provide a method for determining whether to activate a notification in an analyte monitoring system. The method includes receiving a projection time period, determining a measurement of a concentration of an analyte in a sample of bodily fluid, determining whether the measurement of the concentration of the analyte is within a specified range, and determining whether to activate the notification by evaluating whether the concentration of the analyte is projected to be within the specified range at a future time during the projection time period, if the measurement of the concentration of the analyte is not within the specified range.Type: ApplicationFiled: October 14, 2008Publication date: June 25, 2009Inventors: Mahesh Seetharaman, Gil Rivas, Michael Wiklund, Jonathan Kendler
-
Publication number: 20090157430Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.Type: ApplicationFiled: October 14, 2008Publication date: June 18, 2009Inventors: Peter Rule, Gil Rivas
-
Publication number: 20090131861Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.Type: ApplicationFiled: October 10, 2008Publication date: May 21, 2009Applicant: OptiScan Biomedical CorporationInventors: James R. Braig, Richard Keenan, Peter Rule, Gil Rivas, Mahesh Seetharaman